Skip to Content
  • Previous Rank92
  • Revenues ($M)$26,107.00
  • Revenue Percent Change-14.1%
  • Profits ($M)$4,628.00
  • Profits Percent Change-65.7%
  • Assets ($M)$70,283.00
  • Employees10,000
  • Market Value — as of March 29, 2018 ($M)$98,297.30

California-based Gilead is a biopharmaceutical firm best known for its hepatitis C cures Sovaldi and Harvoni.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

John F. Milligan IV
CEO Title
President, Chief Executive Officer & Director
Health Care
HQ Location
Foster City, Calif.
Years on Fortune 500 List10

Gilead Sciences Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$26,107.00-14.1%
Profits ($M)$4,628.00-65.7%
Assets ($M)$70,283.00-
Total Stockholder Equity ($M)$20,442.00-
Market Value — as of March 29, 2018 ($M)$98,297.30-

Profit Ratios

Profit as % of Revenues17.7%
Profits as % of Assets6.6%
Profits as % of Stockholder Equity22.6%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)3.51
EPS % Change (from 2016)-64.7%
EPS % Change (5 year annual rate)16.4%
EPS % Change (10 year annual rate)15.4%

Total Return

Total Return to Investors (2017)2.9%
Total Return to Investors (5 year, annualized)15.8%
Total Return to Investors (10 year, annualized)12.7%